Skip to main content
  • Health and environmental risks associated with emerging pollutants and novel green processes
  • Published:

Pharmaceuticals released from senior residences: occurrence and risk evaluation

Abstract

One of the main pursuits, yet most difficult, in monitoring studies is to identify the sources of environmental pollution. In this study, we have identified health-care facilities from south European countries as an important source of pharmaceuticals in the environment. We have estimated that compounds consumed in by the elderly and released from effluents of senior residences can reach river waters at a concentration higher than 0.01 μg/L, which is the European Medicines Agency (EMA) threshold for risk evaluation of pharmaceuticals in surface waters. This study has been based on five health institutions in Portugal, Spain, and France, with 52 to 130 beds. We have compiled the pharmaceuticals dispensed on a daily base and calculated the consumption rates. From 54.9 to 1801 g of pharmaceuticals are consumed daily, with laxatives, analgesics, antiepileptics, antibiotics, and antidiabetic agents being the main drug families administered. According to excretion rates, dilution in the sewerage system, and elimination in wastewater treatment plants, macrogol, metformin, paracetamol, acetylcysteine, amoxicillin, and gabapentin, among others, are expected to reach river waters. Finally, we discuss the risk management actions related to the discharge of pharmaceuticals from senior residences to surface waters.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  • Al-Khazrajy OSA, Boxall ABA (2016) Risk-based prioritization of pharmaceuticals in the natural environment in Iraq. Environ Sci Pollut Res 23:15712–15726

    CAS  Article  Google Scholar 

  • Amiel ML, Husson MC (1994) The Theriaque database and information on side effects of drugs. Therapie 49:455–459

  • Banjac Z, Ginebreda A, Kuzmanovic M, Marcé R, Nadal M, Riera JM, Barceló D (2015) Emission factor estimation of ca. 160 emerging organic microcontaminants by inverse modeling in a Mediterranean river basin (Llobregat, NE Spain). Sci Total Environ 520:241–252

    CAS  Article  Google Scholar 

  • Barnett J, Breakwell GM (2003) The social amplification of risk and the hazard sequence: the October 1995 oral contraceptive pill scare. Health Risk Soc 5:301–313

    Article  Google Scholar 

  • Besse JP, Kausch-Barreto C, Garric J (2008) Exposure assessment of pharmaceuticals and their metabolites in the aquatic environment: application to the French situation and preliminary prioritization. Hum Ecol Risk Assess 14:665–695

    CAS  Article  Google Scholar 

  • Booker V, Halsall C, Llewellyn N, Johnson A, Williams R (2014) Prioritising anticancer drugs for environmental monitoring and risk assessment purposes. Sci Total Environ 473-474:159–170

    CAS  Article  Google Scholar 

  • Bouder F (2011) Benefit/risk communication by the European Medicines Agency: a study of influential stakeholders’ expectations and attitudes

  • Carlsson C, Johansson AK, Alvan G, Bergman K, Kühler T (2006) Are pharmaceuticals potent environmental pollutants? Part I: Environmental risk assessments of selected active pharmaceutical ingredients. Sci Total Environ 364:67–87

    CAS  Article  Google Scholar 

  • Chartier Y (2014): Safe management of wastes from health-care activities. World Health Organization

  • Donnachie RL, Johnson AC, Sumpter JP (2016) A rational approach to selecting and ranking some pharmaceuticals of concern for the aquatic environment and their relative importance compared with other chemicals. Environ Toxicol Chem 35:1021–1027

    CAS  Article  Google Scholar 

  • EPA US (2013) Exposure assessment tools and models. EPI Suite v4.1. 2013: https://www.epa.gov/tsca-screening-tools/epi-suitetm-estimation-program-interface

  • European Medicines Agency (EMA) (2006) EMEA/CHMP/SWP/4447/00 http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500003978.pdf

  • Fent K, Weston AA, Caminada D (2006) Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76:122–159

    CAS  Article  Google Scholar 

  • Fick J, Lindberg RH, Tysklind M, Larsson DGJ (2010) Predicted critical environmental concentrations for 500 pharmaceuticals. Regul Toxicol Pharmacol 58:516–523

    CAS  Article  Google Scholar 

  • Franquet-Griell H, Gómez-Canela C, Ventura F, Lacorte S (2015) Predicting concentrations of cytostatic drugs in sewage effluents and surface waters of Catalonia (NE Spain). Environ Res 138:161–172

    CAS  Article  Google Scholar 

  • García-Santiago X, Franco-Uría A, Omil F, Lema JM (2016) Risk assessment of persistent pharmaceuticals in biosolids: dealing with uncertainty. J Hazard Mater 302:72–81

    Article  Google Scholar 

  • Gaspar R, Barnett J, Seibt B (2015) Crisis as seen by the individual: the norm deviation approach/La crisis vista por el individuo: el Enfoque de la Desviación de la Norma. Psyecology 6:103–135

    Article  Google Scholar 

  • Gómez-Canela C, Cortés-Francisco N, Oliva X, Pujol C, Ventura F, Lacorte S, Caixach J (2012) Occurrence of cyclophosphamide and epirubicin in wastewaters by direct injection analysis-liquid chromatography-high-resolution mass spectrometry. Environ Sci Pollut Res 19:3210–3218

    Article  Google Scholar 

  • Gómez-Canela C, Ventura F, Caixach J, Lacorte S (2014) Occurrence of cytostatic compounds in hospital effluents and wastewaters, determined by liquid chromatography coupled to high-resolution mass spectrometry. Anal Bioanal Chem 406:3801–3814

    Article  Google Scholar 

  • Herrmann M, Olsson O, Fiehn R, Herrel M, Kümmerer K (2015) The significance of different health institutions and their respective contributions of active pharmaceutical ingredients to wastewater. Environ Internat 85:61–76

  • Kahan DM (2009) Nanotechnology and society: the evolution of risk perceptions. Nat Nanotechnol 4:705–706

    CAS  Article  Google Scholar 

  • Keller VDJ, Williams RJ, Lofthouse C, Johnson AC (2014) Worldwide estimation of river concentrations of any chemical originating from sewage-treatment plants using dilution factors. Environ Toxicol Chem 33:447–452

    CAS  Article  Google Scholar 

  • Kümmerer K, Al-Ahmad A (2010) Estimation of the cancer risk to humans resulting from the presence of cyclophosphamide and ifosfamide in surface water. Environ Sci Pollut Res 17:486–496

    Article  Google Scholar 

  • Langford KH, Thomas KV (2009) Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works. Environ Int 35:766–770

    CAS  Article  Google Scholar 

  • Lichtenstein S, Slovic P (2006): The construction of preference. Cambridge University Press

  • Naidu R, Espana VAA, Liu Y, Jit J (2016) Emerging contaminants in the environment: risk-based analysis for better management. Chemosphere 154:350–357

    CAS  Article  Google Scholar 

  • Oldenkamp R, Huijbregts MAJ, Hollander A, Versporten A, Goossens H, Ragas AMJ (2013) Spatially explicit prioritization of human antibiotics and antineoplastics in Europe. Environ Int 51:13–26

    CAS  Article  Google Scholar 

  • Oosterhuis M, Sacher F, ter Laak TL (2013) Prediction of concentration levels of metformin and other high consumption pharmaceuticals in wastewater and regional surface water based on sales data. Sci Total Environ 442:380–388

    CAS  Article  Google Scholar 

  • Ortiz de García S, Pinto Pinto G, García Encina P, Irusta Mata R (2013) Consumption and occurrence of pharmaceutical and personal care products in the aquatic environment in Spain. Sci Total Environ 444:451–465

    Article  Google Scholar 

  • Pidgeon N, Harthorn B, Satterfield T (2011) Nanotechnology risk perceptions and communication: emerging technologies, emerging challenges. Risk Anal 31:1694–1700

    Article  Google Scholar 

  • Rabiet M, Togola A, Brissaud F, Seidel JL, Budzinski H, Elbaz-Poulichet F (2006) Consequences of treated water recycling as regards pharmaceuticals and drugs in surface and ground waters of a medium-sized mediterranean catchment. Environ Sci Technol 40:5282–5288

    CAS  Article  Google Scholar 

  • Riva F, Zuccato E, Castiglioni S (2015) Prioritization and analysis of pharmaceuticals for human use contaminating the aquatic ecosystem in Italy. J Pharm Biomed Anal 106:71–78

    CAS  Article  Google Scholar 

  • Santos LHMLM, Gros M, Rodriguez-Mozaz S, Delerue-Matos C, Pena A, Barceló D, Montenegro MCBSM (2013) Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: identification of ecologically relevant pharmaceuticals. Sci Total Environ 461-462:302–316

    CAS  Article  Google Scholar 

  • Touraud E, Roig B, Sumpter JP, Coetsier C (2011) Drug residues and endocrine disruptors in drinking water: risk for humans? Int J Hyg Environ Health 214:437–441

    CAS  Article  Google Scholar 

  • van Leeuwen CJ, Vermeire TG (2007): Risk assessment of chemicals: an introduction. Springer Science & Business Media

  • van Nuijs ALN, Covaci A, Beyers H, Bervoets L, Blust R, Verpooten G, Neels H, Jorens PG (2015) Do concentrations of pharmaceuticals in sewage reflect prescription figures? Environ Sci Pollut Res 22:9110–9118

    Article  Google Scholar 

  • Verlicchi P, Galletti A, Petrovic M, Barceló D (2010) Hospital effluents as a source of emerging pollutants: an overview of micropollutants and sustainable treatment options. J Hydrol 389:416–428

    CAS  Article  Google Scholar 

  • Verlicchi P, Al Aukidy M, Zambello E (2012) Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment—a review. Sci Total Environ 429:123–155

    CAS  Article  Google Scholar 

  • WHO (2017) ATC/DDD Index 2017. https://www.whocc.no/atc_ddd_index/

  • Zhang J, Chang VWC, Giannis A, Wang JY (2013) Removal of cytostatic drugs from aquatic environment: a review. Sci Total Environ 445-446:281–298

    CAS  Article  Google Scholar 

Download references

Acknowledgements

This study has been financed by the SUDOE program with the project Innovec’EAU (2016-2019)/Project SOE1/P1/F0173 Interreg Sudoe funded by FEDER (http://innovec-eau.univ-perp.fr). We would like to acknowledge the associated partners of the project: Syndicat National des Établissements et Résidences Privés pour Personnes Âgées (SYNERPA), Jordi Cayetano and Marc Antoni Rovira from Sant Joan de Deu (SJD), Cinta Pascual and Arnald Pannocchia from Llars d’Avis de Catalunya (L’Onada), and Marisa Cristino, Filomena Gerardo, and Sónia Pereira da Silva from Santa Casa da Misericórdia de Lisboa (SCML). We would also like to thank the personnel from the elderly who are acknowledged for their assistance and guidance and for providing consumption data of pharmaceuticals. Silvia Sachetti, Emanuella Scudellaro, and Martina Lula, Erasmus students from the University Federico II in Naples, are gratefully thanked for compiling data and advice on the toxicity of pharmaceuticals.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Silvia Lacorte.

Additional information

Responsible editor: Ester Heath

Electronic supplementary material

Table S1

Compounds consumed in the 5 health institutions from france, Spain and Portugal, the family and the ATC code. (DOCX 22 kb).

Table S2

(DOCX 15 kb).

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lacorte, S., Luis, S., Gómez-Canela, C. et al. Pharmaceuticals released from senior residences: occurrence and risk evaluation. Environ Sci Pollut Res 25, 6095–6106 (2018). https://doi.org/10.1007/s11356-017-9755-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11356-017-9755-1

Keywords

  • Health care institutions
  • Pharmaceuticals
  • Predicted environmental concentrations
  • Risk management